Business
FAE: Double-digit growth in sales and profit, strong cash, and higher dividends mark H1 2024
FAE: Double-digit growth in sales and profit, strong cash, and higher dividends mark H1 2024
About this update from Faes Farma, S.a.
Faes Farma posted double-digit growth in sales, EBITDA, and net profit in H1 2024, driven by international expansion and strong pharma performance, while maintaining a robust balance sheet and increasing shareholder returns.Original document: This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.